Antibiotics, benzoyl peroxide, topical retinoids, and oral isotretinoin received strong recommendations for acne treatment from a panel of experts who drafted an update to the American Academy of ...

Acne is the most common skin condition in the United States and its effects can be devastating. However, successful treatment can be hard to come by. "I have had problems with my skin for as long as I ...

Please provide your email address to receive an email when new articles are posted on . 10.5% of patients treated with isotretinoin experienced mood changes. 88% of patients experienced symptom ...

If you’re someone who’s experienced recurring bouts of cystic acne, you’ll know there’s no one-size-fits-all approach to keeping acne flares at bay. Clearing your skin can feel like a bit of a waiting ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Acne is nobody’s BFF. In fact, it’s the enemy we ...

NEW YORK (Reuters Health) - The oral contraceptive Yasmin, plus a low-dose of the diuretic spironolactone, is a safe and effective treatment for women with severe facial acne, according to the ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Acne is almost a teenage rite of passage, but that doesn’t mean children should be told to “wait it out.” Adolescence brings a surge of hormones that increase oil production, making skin more ...

Rachael Link is a registered dietitian and health writer based in San Francisco. She completed her undergraduate degree at the University of Central Missouri and holds a master’s degree from New York ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...